Nivolumab and Ipilimumab in Advanced Melanoma

N Engl J Med. 2017 Dec 21;377(25):2503-2504. doi: 10.1056/NEJMc1714339.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • Ipilimumab*
  • Melanoma*
  • Nivolumab

Substances

  • Antibodies, Monoclonal
  • Ipilimumab
  • Nivolumab